| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
0.99 |
| Cardiac Surgery |
0 |
0.89 |
| Congenital Heart Disease |
0 |
0.66 |
| Coronary Artery Disease (CAD) |
0 |
0.65 |
| Cerebrovascular Accident |
0 |
0.64 |
| Heart Failure (HF) |
0 |
0.5 |
| Thromboembolism |
0 |
0.5 |
| Heart |
0 |
0.46 |
| Aortic Stenosis |
0 |
0.38 |
| Statins |
0 |
0.38 |
| Stenosis |
0 |
0.38 |
| Atherosclerosis |
0 |
0.26 |
| PCSK9 |
0 |
0.26 |
| Aortic Valve |
0 |
0.23 |
| Biomarker |
0 |
0.23 |
| Europe |
0 |
0.23 |
| Ischemic Stroke |
0 |
0.23 |
| Healthcare and Medical Technology |
0 |
0.16 |
| LDL Cholesterol |
0 |
0.16 |
| Apolipoproteins |
0 |
0.15 |
| Artery |
0 |
0.15 |
| Cardiovascular disease |
0 |
0.15 |
| Child |
0 |
0.15 |
| Clinical Research |
0 |
0.15 |
| Lipoproteins |
0 |
0.98 |
| Dyslipidemia |
0 |
0.08 |
| Endocrinology |
0 |
0.08 |
| Femoral |
0 |
0.08 |
| Genetics |
0 |
0.08 |
| Genomic Medicine |
0 |
0.08 |
| Hypercholesterolemia |
0 |
0.08 |
| Infarction |
0 |
0.08 |
| Meta-Analysis |
0 |
0.08 |
| Metabolism |
0 |
0.08 |
| Myocardial Infarction (MI) |
0 |
0.08 |